Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 651 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Comparison of different glucocorticoid regimens in the management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Ajish T P, Praveen V P, Nisha B, Kumar Harish

Year : 2014| Volume: 18| Issue : 6 | Page no: 815-820

   This article has been cited by
1 Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years
L. L. Iervolino,B. Ferraz-de-Souza,R. M. Martin,F. C. Costa,M. C. Miranda,B. B. Mendonça,T. S. Bachega
Osteoporosis International. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia
Sze May Ng,Karolina M Stepien,Ashma Krishan
Cochrane Database of Systematic Reviews. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Management of Infants with Congenital Adrenal Hyperplasia
Aashima Dabas,Pallavi Vats,Rajni Sharma,Preeti Singh,Anju Seth,Vandana Jain,Prerna Batra,Neerja Gupta,Ravindra Kumar,Madhulika Kabra,Seema Kapoor,Sangeeta Yadav
Indian Pediatrics. 2020; 57(2): 159
[Pubmed]  [Google Scholar] [DOI]
4 Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Emma Whittle,Henrik Falhammar
Journal of the Endocrine Society. 2019; 3(6): 1227
[Pubmed]  [Google Scholar] [DOI]
5 Glucocorticoid replacement regimens in the treatment of 21-hydroxylase deficiency congenital adrenal hyperplasia
Sze May Ng,Karolina Stepien
Cochrane Database of Systematic Reviews. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article